COVID-19: Focusing on the Link between Inflammation, Vitamin D, MAPK Pathway and Oxidative Stress Genetics
-
Published:2023-05-20
Issue:5
Volume:12
Page:1133
-
ISSN:2076-3921
-
Container-title:Antioxidants
-
language:en
-
Short-container-title:Antioxidants
Author:
Cusato Jessica1ORCID, Manca Alessandra1ORCID, Palermiti Alice1ORCID, Mula Jacopo1ORCID, Costanzo Martina1, Antonucci Miriam2ORCID, Chiara Francesco3, De Vivo Elisa Delia1ORCID, Maiese Domenico1, Ferrara Micol2ORCID, Bonora Stefano4, Di Perri Giovanni4, D’Avolio Antonio1ORCID, Calcagno Andrea4ORCID
Affiliation:
1. Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, Corso Svizzera, 164, 10149 Turin, Italy 2. ASL Città di Torino, Amedeo di Savoia Hospital, 10149 Turin, Italy 3. Laboratory of Clinical Pharmacology S.Luigi A.O.U., Department of Clinical and Biological Sciences, University of Turin, Regione Gonzole, Orbassano, 10043 Turin, Italy 4. Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, 10149 Turin, Italy
Abstract
An uncontrolled inflammatory response during SARS-CoV-2 infection has been highlighted in several studies. This seems to be due to pro-inflammatory cytokines whose production could be regulated by vitamin D, ROS production or mitogen-activated protein kinase (MAPK). Several genetic studies are present in the literature concerning genetic influences on COVID-19 characteristics, but there are few data on oxidative stress, vitamin D, MAPK and inflammation-related factors, considering gender and age. Therefore, the aim of this study was to evaluate the role of single nucleotide polymorphisms in these pathways, clarifying their impact in affecting COVID-19-related clinical features. Genetic polymorphisms were evaluated through real-time PCR. We prospectively enrolled 160 individuals: 139 patients were positive for SARS-CoV-2 detection. We detected different genetic variants able to affect the symptoms and oxygenation. Furthermore, two sub-analyses were performed considering gender and age, showing a different impact of polymorphisms according to these characteristics. This is the first study highlighting a possible contribution of genetic variants of these pathways in affecting COVID-19 clinical features. This may be relevant in order to clarify the COVID-19 etiopathogenesis and to understand the possible genetic contribution for further SARS infections.
Subject
Cell Biology,Clinical Biochemistry,Molecular Biology,Biochemistry,Physiology
Reference57 articles.
1. Genetics of COVID-19;Raskin;J. Pediatr.,2020 2. WHO (2023, March 30). WHO Director-Generals Opening Remarks at the Media Briefing on COVID-19—March 2020. Available online: who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. 3. CDC (2023, May 19). Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19: Information for Healthcare Professionals, Available online: cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingconditions.html. 4. Beltran-Garcia, J., Osca-Verdegal, R., Pallardo, F.V., Ferreres, J., Rodriguez, M., Mulet, S., Sanchis-Gomar, F., Carbonell, N., and Garcia-Gimenez, J.L. (2020). Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression. Antioxidants, 9. 5. WHO (2023, April 17). Coronavirus Disease (COVID-19): How Is It Transmitted?. Available online: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-how-is-it-transmitted.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|